Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-086831

SPECTRUM PHARMACEUTICALS INC · SPPI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Rajesh C Shrotriya M.D.
Officer — Chairman & CEO · Director · 10% Owner
Period of report
Dec 22, 2015
Accepted (ET)
Dec 23, 2015 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000831547

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.001 par valueDec 22, 2015M90,750$4.23A101,426IBy Shrotriya Gift Trust
Common Stock, $0.001 par valueF1Dec 22, 2015F65,732$5.84D35,694IBy Shrotriya Gift Trust
Common Stock, $0.001 par valueDec 22, 2015M38,498$4.23A38,498IBy Shrotriya Annuity Trust
Common Stock, $0.001 par valueF1Dec 22, 2015F27,885$5.84D10,613IBy Shrotriya Annuity Trust
Common Stock, $0.001 par valueholding———1,766,740D
Common Stock, $0.001 par valueholding———498,894IBy CS Family Trust
Common Stock, $0.001 par valueholding———26,128IBy 401(k) Plan
Common Stock, $0.001 par valueholding———9,523IBy Spouse
Common Stock, $0.001 par valueholding———78,089IBy Shrotriya Family Foundation

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option Exercise (Right to Buy)$4.23Dec 22, 2015M90,750DJan 1, 2009Jan 1, 2016Common Stock90,7500I
Stock Option Exercise (Right to Buy)$4.23Dec 22, 2015M38,498DJan 1, 2009Jan 1, 2016Common Stock38,4980I

Explanation of responses